Author's Reply to Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal. [electronic resource]
- European journal of ophthalmology 11 2017
- e192 p. digital
Publication Type: Letter; Comment
1724-6016
10.5301/ejo.5001015 doi
Bevacizumab Humans Portugal Ranibizumab Retinal Vein Retinal Vein Occlusion Vascular Endothelial Growth Factor A